Лидокаин 20 мг/мл 2 мл раствор для инъекций

Country: Kyrgyzstan

Bahasa: Rusia

Sumber: Правительства Кыргызской Республики (Департамент лекарственного обеспечения и медицинской техники)

Bahan aktif:

Лидокаин

Boleh didapati daripada:

АО Новосибхимфарм

Kod ATC:

D04AB01

INN (Nama Antarabangsa):

Lidocaine

Dos:

20 мг/мл 2 мл

Borang farmaseutikal:

раствор для инъекций

Unit dalam pakej:

№10

Jenis preskripsi:

по рецепту

Dikeluarkan oleh:

АО Новосибхимфарм (Россия)

Kawasan terapeutik:

Местноанестезирующее, антиаритмическое средство

Ringkasan produk:

ПЖВЛС: да

Tarikh kebenaran:

2016-12-14

Ciri produk

{-
..
yTBEPXTAAIO
Ieuepa;rrunrft
quperrop
Aen
pcTBeHHOTO
o0ec[eq
IfKI'
Mr.r
t4fl
tIHCTpyKrItIfl
tIOMEAI,IUI,IHCKOMyIIPIIMEHEHI,I
CPEACTBA
JIIINOKAIIH
Perucrpaquonnuft
HoMep
Topronoe
HarrMeHoBanue
Jlra4orazn
MexgyHapoAHoe
HerrareHToBaHHoe
HanMeuoBaurae
Jln4oxauu
JlercapcrneHHafl
Qopnra
Pacrnop
4lx
llurerqufi
Cocrae
Arcmuauoe
seu4ecmso:
Jrr4AoKauHa
rr.rApoxnopug (n
uepecr{ere Ha 100
%
neruecrno)
-
20 rur
B
c
noa o
z
amenb
H
bte s
eu4e
c
m6
a
HarpLrflxJroplrA-6ur
Harpur rr4ApoKclrAa
pacrBop
1M
-
Ao
pH
5,0
-
7,0
BoAa
Anf,
aHrexuufi
-.qo
I un
Ouucanue
flpo:pauuar
6 ecqeerHar
HJrra
cJrerKa
oKparxeHH
aJ{
xr,rAKocrb.
@apuarorepafleBTuqecKaq
rpyrrrra
Asacrerurr4
MecrHbre.
AuzAu
Koa
ATX:N01BB02
(DapuaxonoruqecKr.re
ceoft
crsa
(DapuarcoduHaMuKa
IlurorauH
flBrfl.ercfl.
KoporKoAeftcreylouzM
MecrHbrM
aHecrerr4KoM
aMr,rAHoro
rr,r[a.
B ocHone
ero MexaHI4sN,Ia
AeficrsvIf,
Irelr.]l1rT
yMeHbrxeHHe
rrpoHr{UaeMocrl,r
naeu6paHrr
ueftpoua
AJrr
rroHoB
Harpu{.
B
perynrrare
STofo
cHllxaercs
cKopocrb
Aenonspra3a\uu
pr
rroBbrrrraercs
lopor
nor6yN4enrlt,
rpLIBoAx
r
o6parzMoMy
MecrHoMy
oHeMeHr4ro.
JInAoxauH
rrprrMeHsror
B rlen.f,x
AocrI'IXeHI4fl
npoBoAHuxogofi
aHecre3I4I,I
B
pa3nr,rrrHblx
f{acrKax
reJla
I,I KoHTpoJIt
aputvtuit.
O6nalaer
6ucrprurr
HaqaJIoM
[eitctsus.
(orcono
oAnofi MrrHyrbr
nocJre
BHyrpr{BeuHoro
BBeAeHrat
I4 nsrHaAIIarL
MIrHyr
nocre
BHyrpl4Mbrureuuoro),
6trcrpo
paclpocrpaHflercfl.
B oKpyxalouue
rKaHu.
leftcrnue
npoAonlKaercq
l0-20
MI4Hyr
H
oxono
60-90 Mr4Hyr
nocJre
BHyrpriBeHHoro
H
BHyTpI4MbIIIIeTTHOf
O BBeIeHI,It
COOTBeTCTBeHHO.
@apuarcorcuHemuKa
A6cop64un
JlzAoxaun
6ucrpo
a6cop6upyercr
r43
xenyAorrHo-Kr.rurelrHoro
rpaKTa,
oAHaKo
BcJreAcrBue
eQ$exra
(nepBllqHofo
npoxoxAeHl4r)
rrepe3
rrerreHb
Jrr{rrrb
ue6olrruoe
ero
KoJrr.rqecrBo
AOCTraraeT
cI,rcTeMHoro
KpoBoToKa.
Czcrevuas
a6cop6qas
Jrr.rAoKarzHa
onpeAenrercf,
MecroM
BBeAeHr.rs,
,qotofr
r4
efo
SapruaronoraqecKuM
npoQunervr.
Marcuualbr-rair
KoHrIeHTparrHr
B KpoBr.r
Aocrr,rraercs
nocJre
Itexpe6epnoft
6loxaAbl,
AaJIee
(n
nopr4xe
cHuxeHur
KoHrleHTpagnu),
rocJre
BBeAeHr.rf,
B
[Iog